MDGL vs. SPY
Compare and contrast key facts about Madrigal Pharmaceuticals, Inc. (MDGL) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MDGL or SPY.
Correlation
The correlation between MDGL and SPY is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MDGL vs. SPY - Performance Comparison
Key characteristics
MDGL:
0.61
SPY:
2.21
MDGL:
1.39
SPY:
2.93
MDGL:
1.17
SPY:
1.41
MDGL:
0.68
SPY:
3.26
MDGL:
2.53
SPY:
14.43
MDGL:
15.63%
SPY:
1.90%
MDGL:
64.36%
SPY:
12.41%
MDGL:
-98.40%
SPY:
-55.19%
MDGL:
-24.74%
SPY:
-2.74%
Returns By Period
In the year-to-date period, MDGL achieves a 33.30% return, which is significantly higher than SPY's 25.54% return. Over a longer period, both investments have demonstrated similar performance, with their 10-year annualized returns being quite close: MDGL at 12.97% and SPY at 12.97%.
MDGL
33.30%
-2.73%
10.78%
38.75%
28.12%
12.97%
SPY
25.54%
-0.42%
8.90%
25.98%
14.66%
12.97%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MDGL vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Madrigal Pharmaceuticals, Inc. (MDGL) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MDGL vs. SPY - Dividend Comparison
MDGL has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 0.86%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDGL Madrigal Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 0.86% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% | 1.81% |
Drawdowns
MDGL vs. SPY - Drawdown Comparison
The maximum MDGL drawdown since its inception was -98.40%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for MDGL and SPY. For additional features, visit the drawdowns tool.
Volatility
MDGL vs. SPY - Volatility Comparison
Madrigal Pharmaceuticals, Inc. (MDGL) has a higher volatility of 11.87% compared to SPDR S&P 500 ETF (SPY) at 3.72%. This indicates that MDGL's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.